About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Vitamin D and Omega-3 Inhibit Metabolic Syndrome

NCT01326442·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Guelph

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

must have Metabolic Syndrome as defined by International Diabetes Federation
must be able to swallow tablets and capsules
must be 18 years of age or older
must be physically capable of moderate intensity exercise

You may not be if

pregnant or lactating
vegetarian

The record

StatusCompleted

PhasePhase 3

Taking part40

StartedApr 2011

UpdatedJun 13, 2013

Conditions

Type 2 Diabetes Mellitus Hypertension Hyperlipidemia Obesity

Where1

University of Guelph
Guelph, Ontario, Canada

Clareo Health | Vitamin D and Omega-3 Inhibit Metabolic Syndrome